Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
Methodological detailsexecutive summary, expert committee, evidence-based, expert consensus, public comment, Draft recommendations evaluated by invited reviewers and presented for public comment, Reviewed by the Evidence Based Laboratory Medicine Committee and Board of Directors of the American Association for Clinical Chemistry and the Professional Practice Committee of the ADA
- Executive summary
- Expert committee
- Evidence-based
- Expert consensus
- Public comment
- Draft recommendations evaluated by invited reviewers and presented for public comment
- Reviewed by the Evidence Based Laboratory Medicine Committee and Board of Directors of the American Association for Clinical Chemistry and the Professional Practice Committee of the ADA
Recommendations
As issued by the authors
DM can be diagnosed by increased venous plasma glucose or increased blood hemoglobin A1c (HbA1c)
Glycemic control is monitored by SMBG with meters and/or continuous interstitial glucose monitoring, and by laboratory HbA1c
Roles of noninvasive glucose monitoring, genetic testing, and measurement of ketones, autoantibodies, urine albumin, insulin, proinsulin and C-peptide are addressed
Several analytes have minimal clinical value at present; their measurement is not recommended
Original publication
Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Diabetes Care. Published 20 July 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →